Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

Clinical trial NCT02157181 · COMPLETED

Trial details

NCT number: NCT02157181
Sponsor: Jurgen Barth
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hairy Cell Leukemia (HCL)

Start date: 2004-06-01
Primary completion: 2012-09-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.